Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zidebactam metabolism and excretion in healthy males
NCT07247942Phase 1Completed
- Sponsor
- Wockhardt
- Start
- Dec 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of zidebactam in bacterial infection, sponsored by Wockhardt. Primary endpoints: Amount Excreted in Urine at 7 days, Cumulative Amount Excreted in Urine at 7 days and 7 more. Started Dec 2017; status: completed.
02
Drugs
zidebactam
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT07247942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07247942.